首页> 美国卫生研究院文献>Materials >Fabrication of a Delaying Biodegradable Magnesium Alloy-Based Esophageal Stent via Coating Elastic Polymer
【2h】

Fabrication of a Delaying Biodegradable Magnesium Alloy-Based Esophageal Stent via Coating Elastic Polymer

机译:通过涂层弹性聚合物制备可延迟降解的镁合金基食管支架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Esophageal stent implantation can relieve esophageal stenosis and obstructions in benign esophageal strictures, and magnesium alloy stents are a good candidate because of biodegradation and biological safety. However, biodegradable esophageal stents show a poor corrosion resistance and a quick loss of mechanical support in vivo. In this study, we chose the elastic and biodegradable mixed polymer of Poly(ε-caprolactone) (PCL) and poly(trimethylene carbonate) (PTMC) as the coated membrane on magnesium alloy stents for fabricating a fully biodegradable esophageal stent, which showed an ability to delay the degradation time and maintain mechanical performance in the long term. After 48 repeated compressions, the mechanical testing demonstrated that the PCL-PTMC-coated magnesium stents possess good flexibility and elasticity, and could provide enough support against lesion compression when used in vivo. According to the in vitro degradation evaluation, the PCL-PTMC membrane coated on magnesium was a good material combination for biodegradable stents. During the in vivo evaluation, the proliferation of the smooth muscle cells showed no signs of cell toxicity. Histological examination revealed the inflammation scores at four weeks in the magnesium-(PCL-PTMC) stent group were similar to those in the control group (p > 0.05). The α-smooth muscle actin layer in the media was thinner in the magnesium-(PCL-PTMC) stent group than in the control group (p < 0.05). Both the epithelial and smooth muscle cell layers were significantly thinner in the magnesium-(PCL-PTMC) stent group than in the control group. The stent insertion was feasible and provided reliable support for at least four weeks, without causing severe injury or collagen deposition. Thus, this stent provides a new stent for the treatment of benign esophageal stricture and a novel research path in the development of temporary stents in other cases of benign stricture.
机译:食管支架植入术可以缓解食管狭窄和良性食管狭窄的梗阻,镁合金支架由于其生物降解性和生物安全性而非常适合。然而,可生物降解的食管支架在体内显示出较差的耐腐蚀性和机械支撑的快速丧失。在这项研究中,我们选择了聚ε-己内酯(PCL)和聚碳酸三亚甲基酯(PTMC)的可生物降解的弹性混合聚合物作为镁合金支架上的覆膜,以制造完全可生物降解的食道支架。能够延迟降解时间并长期保持机械性能。经过48次反复加压后,机械测试表明PCL-PTMC涂层镁支架具有良好的柔韧性和弹性,并且在体内使用时可以提供足够的支持以防病变压缩。根据体外降解评估,涂在镁上的PCL-PTMC膜是可生物降解支架的良好材料组合。在体内评估期间,平滑肌细胞的增殖没有显示出细胞毒性的迹象。组织学检查显示,镁-(PCL-PTMC)支架组在第4周的炎症评分与对照组相似(p> 0.05)。镁-(PCL-PTMC)支架组的介质中的α-平滑肌肌动蛋白层比对照组薄(p <0.05)。镁-(PCL-PTMC)支架组的上皮和平滑肌细胞层均比对照组薄得多。支架插入是可行的,并提供了至少四个星期的可靠支撑,而不会造成严重伤害或胶原沉积。因此,该支架为治疗良性食道狭窄提供了一种新的支架,并为其他良性狭窄情况下的临时支架的开发提供了新的研究途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号